More recently, two meta-analyses assessed circulating irisin levels in NAFLD patients, and the results suggested that irisin levels in NAFLD patients were similar to that in control populations and were less likely to be affected by disease severity and racial/ethnic disparities (57, 58). Here, FNDC5 is linked to metabolic dysfunction-associated steatotic liver disease.